Clinical Trial: Effect of Nicotinic Acid as Add on Therapy in Patients Receiving ? Blocker for Prophylaxis of Moderate to Severe Migraine
Study Status: Completed
Recruit Status: RECRUITING
Condition: Migraine Prophylaxis
Study Type: INTERVENTIONAL
Official Title: Effect of Nicotinic Acid as add-on Therapy in Patients Receiving ? Blocker for Prophylaxis of Moderate to Severe Migraine: A Randomized, Double-blind, Placebo-controlled Trial
Brief Summary:
This is a prospective single center, randomized, double-blind, 3 arm placebo-controlled study in subjects with migraine headache requiring prophylactic treatment.The patients will be randomized to receive Nicotinic Acid Extended-release tablet 500 mg or 1000 mg or placebo for 12 weeks.The safety and efficacy outcome measures will be assessed at baseline and 12 weeks.
Read more